Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TRPC1 | P48995 | 1/20 | 0.31 |
| ▸ | TRPC3 | Q13507 | 1/20 | 0.31 |
| ▸ | STIM1 | Q13586 | 1/20 | 0.31 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.31 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.30 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.30 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.30 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30750946 | 0.85 | ALDH1A1 (0.33) | TP53SMN1; SMN2TRPC1TRPC3STIM1 | |
| SCHEMBL38910 | 0.85 | ALDH1A1 (0.33) | TP53SMN1; SMN2TRPC1TRPC3STIM1 | |
| SCHEMBL7561296 | 0.85 | ALDH1A1 (0.33) | TP53SMN1; SMN2TRPC1TRPC3STIM1 | |
| Clopyralid SCHEMBL7589112 | 0.80 | RIPK1 (0.34) | TP53SMN1; SMN2TRPC1TRPC3STIM1 | |
| SCHEMBL7535199 | 0.80 | NTRK1 (0.37) | TRPC1TRPC3STIM1ORAI1NTRK1 | |
| Tebutam SCHEMBL7580831 | 0.78 | MEN1 (0.34) | TP53SMN1; SMN2NTRK1 | |
| SCHEMBL7581102 | 0.77 | CYP3A4 (0.33) | TP53SMN1; SMN2RIPK1NTRK1 | |
| SCHEMBL27320851 | 0.77 | MAPT (0.34) | TP53SMN1; SMN2RIPK1NTRK1 | |
| Bentazon SCHEMBL7587448 | 0.77 | KDM4E (0.43) | — | |
| Pyrazon SCHEMBL7582671 | 0.76 | TRPC1 (0.35) | TP53SMN1; SMN2TRPC1TRPC3STIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | TP53 4303/4885SMN1; SMN2 4618/4885TRPC1 3944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.